Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates

分组1 - Evolus, Inc. reported quarterly earnings of $0.06 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.01 per share a year ago [1] - The company posted revenues of $90.3 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 0.98% and up from $78.95 million year-over-year [2] - Evolus shares have declined approximately 35.5% since the beginning of the year, contrasting with the S&P 500's gain of 0.5% [3] 分组2 - The earnings outlook for Evolus is uncertain, with current consensus EPS estimates at -$0.11 for the coming quarter and -$0.04 for the current fiscal year, alongside revenues of $71.74 million and $330.94 million respectively [7] - The Zacks Industry Rank indicates that the Medical - Products sector is in the bottom 41% of over 250 Zacks industries, suggesting potential underperformance compared to higher-ranked industries [8] - The estimate revisions trend for Evolus was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6]